137 related articles for article (PubMed ID: 6431618)
1. Aspect of the pharmacokinetics of slow-release lithium carbonate.
Hart GA
S Afr Med J; 1984 Aug; 66(5):178-9. PubMed ID: 6431618
[TBL] [Abstract][Full Text] [Related]
2. Bioavailability of lithium carbonate and lithium citrate: a comparison of two controlled-release preparations.
Tyrer SP; Peat MA; Minty PS; Luchini A; Glud V; Amdisen A
Pharmatherapeutica; 1982; 3(4):243-6. PubMed ID: 6815664
[TBL] [Abstract][Full Text] [Related]
3. Serum levels and pharmacokinetics of ordinary and sustained-release lithium carbonate in manic patients during chronic dosage.
Thornhill DP
Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):257-61. PubMed ID: 3089950
[TBL] [Abstract][Full Text] [Related]
4. Absorption and disposition kinetics of lithium carbonate following administration of conventional and controlled release formulations.
Arancibia A; Corvalan F; Mella F; Concha L
Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):240-5. PubMed ID: 3089949
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of standard and slow-release oral lithium carbonate products.
Wallis J; Miller R; McFadyen ML; Carlile JB
S Afr Med J; 1989 Dec; 76(11):618-20. PubMed ID: 2512655
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of lithium preparations in patients.
Johnson GF; Hunt GE
Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(1):63-70. PubMed ID: 6427848
[TBL] [Abstract][Full Text] [Related]
7. Steady-state lithium blood level fluctuations in man following administration of a lithium carbonate conventional and controlled-release dosage form.
Caldwell HC; Westlake WJ; Schriver RC; Bumbier EE
J Clin Pharmacol; 1981; 21(2):106-9. PubMed ID: 6785324
[TBL] [Abstract][Full Text] [Related]
8. Serum concentrations of lithium after three proprietary preparations of lithium carbonate (Priadel, Phasal and Camcolit).
Bennie EH; Manzoor AK; Scott AM; Fell GS
Br J Clin Pharmacol; 1977 Aug; 4(4):479-83. PubMed ID: 901741
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of dosage schedules for delayed-action lithium carbonate].
Balon R; Kabesh Ia
Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(2):264-6. PubMed ID: 6803477
[No Abstract] [Full Text] [Related]
10. Absorption of lithium following administration of slow-release and conventional preparations.
Tyrer S; Hullin RP; Birch NJ; Goodwin JC
Psychol Med; 1976 Feb; 6(1):51-8. PubMed ID: 935297
[TBL] [Abstract][Full Text] [Related]
11. [Serum lithium levels after slow-release and regular tablets of lithium carbonate].
Kauko K; Viukari M
Duodecim; 1973; 89(19):1324-8. PubMed ID: 4757404
[No Abstract] [Full Text] [Related]
12. Prediction of lithium carbonate dosage in psychiatric inpatients using the repeated one-point method.
Marr MA; Djuric PE; Ritschel WA; Garver DL
Clin Pharm; 1983; 2(3):243-8. PubMed ID: 6411413
[TBL] [Abstract][Full Text] [Related]
13. [Voluntary lithium salt poisoning; risks of slow release forms].
Branger B; Peyrière H; Zabadani B; Vécina F; Abbar M
Nephrologie; 2000; 21(6):291-3. PubMed ID: 11117108
[TBL] [Abstract][Full Text] [Related]
14. Single dose pharmacokinetics of 5 formulations of lithium: a controlled comparison in healthy subjects.
Shelley RK; Silverstone T
Int Clin Psychopharmacol; 1986 Oct; 1(4):324-31. PubMed ID: 3104448
[TBL] [Abstract][Full Text] [Related]
15. The single-dose bioavailability of different lithium carbonate products.
Tsang HY; Chen CC; Wen JK
Taiwan Yi Xue Hui Za Zhi; 1987 May; 86(5):543-8. PubMed ID: 3114414
[No Abstract] [Full Text] [Related]
16. Pharmacokinetics of standard (lithicarb) and sustained-release (Priadel) lithium carbonate preparations in patients.
Johnson GF; Hunt GE; Lewis J; St George B
Aust N Z J Psychiatry; 1982 Mar; 16(1):64-8. PubMed ID: 6810866
[TBL] [Abstract][Full Text] [Related]
17. Accuracy and safety of a priori lithium loading.
Kook KA; Stimmel GL; Wilkins JN; Spangher GG
J Clin Psychiatry; 1985 Feb; 46(2):49-51. PubMed ID: 3918024
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the dosage schedules during the administration of retarded lithium carbonate.
Balon R; Kabes J
Act Nerv Super (Praha); 1981 Dec; 23(4):278-80. PubMed ID: 6801905
[No Abstract] [Full Text] [Related]
19. Evaluation of a slow-release lithium carbonate formulation.
Cooper TB; Simpson GM; Lee JH; Bergner PE
Am J Psychiatry; 1978 Aug; 135(8):917-22. PubMed ID: 665833
[TBL] [Abstract][Full Text] [Related]
20. [Comparative characteristics of the preventive properties of short-acting and delayed-action lithium carbonate in endogenous affective psychoses].
Panteleeva GP; Mikhaĭlova NM; Beliaev BS
Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(3):406-12. PubMed ID: 6789585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
